JNBA Financial Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

JNBA Financial Advisors’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-13	Closed	–	–	753
2019 Q2	$0	Buy	+13	New	+$62	﹤0.01%	714
2016 Q3	–	Sell	-159	Closed	-$7K	–	1722
2016 Q2	$7K	Hold	159	–	–	﹤0.01%	386
2016 Q1	$10K	Hold	159	–	–	﹤0.01%	356
2015 Q4	$10K	Hold	159	–	–	﹤0.01%	349
2015 Q3	$11K	Hold	159	–	–	﹤0.01%	349
2015 Q2	$15K	Hold	159	–	–	0.01%	319
2015 Q1	$15K	Hold	159	–	–	0.01%	328
2014 Q4	$14K	Hold	159	–	–	0.01%	329
2014 Q3	$11K	Hold	159	–	–	0.01%	360
2014 Q2	$9K	Hold	159	–	–	﹤0.01%	369
2014 Q1	$6K	Buy	+159	New	+$6.8K	﹤0.01%	377

Other funds holding MACK

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $1.84B AUM 18.57% 1-Year Est. Return

WIM

Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

JNBA Financial Advisors's MACK Position: Q3 2019 in Review

JNBA Financial Advisors sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2019, closing a stake of 13 shares.

JNBA Financial Advisors first reported a position in MACK in Q1 2014 and held it in 11 quarters. The position peaked at $15K in Q2 2015. 47 funds tracked by Wall St. Rank hold MACK as of Q3 2019.

JNBA Financial Advisors reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
JNBA Financial Advisors sold 13 Merrimack Pharmaceuticals, Inc. shares in Q3 2019.
JNBA Financial Advisors first reported a position in Merrimack Pharmaceuticals, Inc. in Q1 2014 and held it in 11 quarters.
JNBA Financial Advisors's Merrimack Pharmaceuticals, Inc. position peaked at $15K in Q2 2015.
47 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2019.

Based on JNBA Financial Advisors's 13F filing for Q3 2019, filed 1 Nov 2019.